title: Pharmacologic Therapy for Type 2 Diabetes: Synopsis of the 2017 American Diabetes Association Standards of Medical Care in Diabetes.
abstract: METHODS
  The American Diabetes Association (ADA) annually updates the Standards of Medical Care in Diabetes to provide clinicians, patients, researchers, payers, and other interested parties with evidence-based recommendations for the diagnosis and management of patients with diabetes.
  
  
  METHODS
  For the 2017 Standards, the ADA Professional Practice Committee updated previous MEDLINE searches performed from 1 January 2016 to November 2016 to add, clarify, or revise recommendations based on new evidence. The committee rates the recommendations as A, B, or C, depending on the quality of evidence, or E for expert consensus or clinical experience. The Standards were reviewed and approved by the Executive Committee of the ADA Board of Directors, which includes health care professionals, scientists, and laypersons. Feedback from the larger clinical community informed revisions.
  
  
  CONCLUSIONS
  This synopsis focuses on recommendations from the 2017 Standards about pharmacologic approaches to glycemic treatment of type 2 diabetes.
authors.affiliation: From St. Mark's Hospital and St. Mark's Diabetes Center, Salt Lake City, Utah; University of Michigan, Ann Arbor, Michigan; SinfoníaRx, Tucson, Arizona Glytec, Greenville, South Carolina; Touro University College of Osteopathic Medicine, Vallejo, California; Abington-Jefferson Health, Jenkintown, Pennsylvania; and Johns Hopkins University, Baltimore, Maryland.
authors.forename: James J
authors.initials: JJ
authors.lastname: Chamberlain
authors.affiliation: From St. Mark's Hospital and St. Mark's Diabetes Center, Salt Lake City, Utah; University of Michigan, Ann Arbor, Michigan; SinfoníaRx, Tucson, Arizona Glytec, Greenville, South Carolina; Touro University College of Osteopathic Medicine, Vallejo, California; Abington-Jefferson Health, Jenkintown, Pennsylvania; and Johns Hopkins University, Baltimore, Maryland.
authors.forename: William H
authors.initials: WH
authors.lastname: Herman
authors.affiliation: From St. Mark's Hospital and St. Mark's Diabetes Center, Salt Lake City, Utah; University of Michigan, Ann Arbor, Michigan; SinfoníaRx, Tucson, Arizona Glytec, Greenville, South Carolina; Touro University College of Osteopathic Medicine, Vallejo, California; Abington-Jefferson Health, Jenkintown, Pennsylvania; and Johns Hopkins University, Baltimore, Maryland.
authors.forename: Sandra
authors.initials: S
authors.lastname: Leal
authors.affiliation: From St. Mark's Hospital and St. Mark's Diabetes Center, Salt Lake City, Utah; University of Michigan, Ann Arbor, Michigan; SinfoníaRx, Tucson, Arizona Glytec, Greenville, South Carolina; Touro University College of Osteopathic Medicine, Vallejo, California; Abington-Jefferson Health, Jenkintown, Pennsylvania; and Johns Hopkins University, Baltimore, Maryland.
authors.forename: Andrew S
authors.initials: AS
authors.lastname: Rhinehart
authors.affiliation: From St. Mark's Hospital and St. Mark's Diabetes Center, Salt Lake City, Utah; University of Michigan, Ann Arbor, Michigan; SinfoníaRx, Tucson, Arizona Glytec, Greenville, South Carolina; Touro University College of Osteopathic Medicine, Vallejo, California; Abington-Jefferson Health, Jenkintown, Pennsylvania; and Johns Hopkins University, Baltimore, Maryland.
authors.forename: Jay H
authors.initials: JH
authors.lastname: Shubrook
authors.affiliation: From St. Mark's Hospital and St. Mark's Diabetes Center, Salt Lake City, Utah; University of Michigan, Ann Arbor, Michigan; SinfoníaRx, Tucson, Arizona Glytec, Greenville, South Carolina; Touro University College of Osteopathic Medicine, Vallejo, California; Abington-Jefferson Health, Jenkintown, Pennsylvania; and Johns Hopkins University, Baltimore, Maryland.
authors.forename: Neil
authors.initials: N
authors.lastname: Skolnik
authors.affiliation: From St. Mark's Hospital and St. Mark's Diabetes Center, Salt Lake City, Utah; University of Michigan, Ann Arbor, Michigan; SinfoníaRx, Tucson, Arizona Glytec, Greenville, South Carolina; Touro University College of Osteopathic Medicine, Vallejo, California; Abington-Jefferson Health, Jenkintown, Pennsylvania; and Johns Hopkins University, Baltimore, Maryland.
authors.forename: Rita Rastogi
authors.initials: RR
authors.lastname: Kalyani
mesh_terms: D003924:Diabetes Mellitus, Type 2 / Q000097:blood / Q000188:drug therapy*; D016527:Drug Costs; D004359:Drug Therapy, Combination; D019317:Evidence-Based Medicine; D006442:Glycated Hemoglobin / Q000032:analysis; D006801:Humans; D007004:Hypoglycemic Agents / Q000009:adverse effects / Q000191:economics / Q000627:therapeutic use*; D007328:Insulin / Q000009:adverse effects / Q000191:economics / Q000627:therapeutic use; D008687:Metformin / Q000009:adverse effects / Q000627:therapeutic use
chemical_list: D006442:Glycated Hemoglobin; D007004:Hypoglycemic Agents; D007328:Insulin; D008687:Metformin